Trial
NCT02538471
LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
University of California, Los Angeles
Condition
Metastatic Breast Cancer
Intervention
Radiation therapy
Why stopped
The study was terminated due to lack of patient accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-09